{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:31:03Z","timestamp":1740807063660,"version":"3.38.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.brachy.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T21:56:38Z","timestamp":1735077398000},"page":"273-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative high-dose-rate brachytherapy alone in stage T1-3N0M0 oral cancer with negative prognostic factors: A retrospective study"],"prefix":"10.1016","volume":"24","author":[{"given":"Lubo\u0161","family":"Tu\u010dek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5972-3866","authenticated-orcid":false,"given":"Igor","family":"Sir\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9619-0536","authenticated-orcid":false,"given":"Denisa","family":"Pohankov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Ka\u0161aov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-1344","authenticated-orcid":false,"given":"Jakub","family":"Grepl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-3800","authenticated-orcid":false,"given":"Petr","family":"Paluska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Hodek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-7505","authenticated-orcid":false,"given":"Milan","family":"Vo\u0161mik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banni Aml","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3413-4149","authenticated-orcid":false,"given":"Eva","family":"\u010cerm\u00e1nkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-7399","authenticated-orcid":false,"given":"Ji\u0159\u00ed","family":"Petera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.03.001_bib0001","first-page":"1","article-title":"High dose rate versus low dose rate brachytherapy for oral cancer \u2013 a meta-analysis of clinical trials","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.brachy.2024.03.001_bib0002","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijom.2005.02.015","article-title":"A comparison of brachytherapy and surgery for the treatment of stage I \u2013 II squamous cell carcinoma of the tongue","volume":"34","author":"Umeda","year":"2005","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.brachy.2024.03.001_bib0003","unstructured":"NCCN Clinical Practice Guidelines in Oncology Version 3. Head and Neck Cancers. 2021. Available online, https:\/\/www.nccn.org\/professionals\/physician_gls\/head-and-neck.pdf, (accessed on 1 November 2021)."},{"key":"10.1016\/j.brachy.2024.03.001_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104627","article-title":"Management of early oral cavity squamous cancers","volume":"104","author":"Chatterjee","year":"2020","journal-title":"Oral Oncology"},{"key":"10.1016\/j.brachy.2024.03.001_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40463-020-00467-w","article-title":"The role of brachytherapy for margin control in oral tongue squamous cell carcinoma","volume":"49","author":"Ianovski","year":"2020","journal-title":"J Otolaryngol. Head Neck Surg"},{"key":"10.1016\/j.brachy.2024.03.001_bib0006","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s00066-022-01901-w","article-title":"Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumors","volume":"198","author":"Tak\u00e1csi-Negy","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brachy.2014.08.050","article-title":"High-dose-rate brachytherapy in early oral cancer with close or positive margins","volume":"1","author":"Petera","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.001_bib0008","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archotol.1977.00780210068007","article-title":"Surgical treatment of squamous cell carcinoma of the oral tongue: factors influencing survival","volume":"103","author":"Whitehurst","year":"1977","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0009","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/0360-3016(90)90346-L","article-title":"Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue","volume":"19","author":"Mazeron","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.001_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0167-8140(91)90036-G","article-title":"Interstitial irradiation for carcinoma of the tongue and floor of mouth. Royal Marsden Hospital Experience 1970 \u20131986","volume":"21","author":"Dearnaley","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0011","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0360-3016(87)90095-2","article-title":"The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma","volume":"13","author":"Chen","year":"1987","journal-title":"Int J Radiatr Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.001_bib0012","first-page":"235","article-title":"Does clearance of positive margins improve local control in oral cavity cancer? A meta-analysis","volume":"161","author":"Bulbub","year":"2019","journal-title":"Head and Neck Surg"},{"key":"10.1016\/j.brachy.2024.03.001_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2022.105850","article-title":"Positive margins matter regardless of subsequent resection findings","volume":"128","author":"Coutu","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0014","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/cncr.31531","article-title":"The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: an international collaborative study","volume":"124","author":"Fridman","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2024.03.001_bib0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.critrevonc.2019.08.003","article-title":"Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2N0-1): A review","volume":"143","author":"Invaldi","year":"2019","journal-title":"Criti. Rev. Oncol.\/hematol."},{"key":"10.1016\/j.brachy.2024.03.001_bib0016","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s13193-020-01075-w","article-title":"Brachytherapy for oral cancers in the era of IMRT","volume":"11","author":"Alva","year":"2020","journal-title":"Indian J. Surg. Oncol."},{"key":"10.1016\/j.brachy.2024.03.001_bib0017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0360-3016(00)00538-1","article-title":"Postoperative brachytherapy alone for T1-2N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins","volume":"48","author":"Lapeyre","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.001_bib0018","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/PL00002416","article-title":"Interstitial brachytherapy with Ir 192 Low Dose Rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx","volume":"7","author":"Grabenbauer","year":"2001","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brachy.2014.09.011","article-title":"Postoperative interstitial brachytherapy for resectable squamous cell carcijoma of the tongue","volume":"14","author":"Goineau","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.001_bib0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00066-021-01870-6","article-title":"Adjuvant brachytherapy for oral squamous cell carcinoma: a single-center experience comparing low-dose and pulsed-dose-rate techniques","volume":"198","author":"Mattei","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0021","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.joms.2011.02.012","article-title":"Incidence of oral cancer occult metastasis and survival of T1-2N0 oral cancer patients","volume":"69","author":"El-Naas","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.brachy.2024.03.001_bib0022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(03)00187-7","article-title":"Neck node metastasis after successful brachytherapy for early stage tongue carcinoma","volume":"68","author":"Nakagawa","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0023","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0360-3016(99)00068-1","article-title":"Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue. Factors influencing local control and soft tissue complications","volume":"44","author":"Fujita","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.001_bib0024","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1056\/NEJMoa1506007","article-title":"Elective versus therapeutic neck dissection in node-negative oral cancer","volume":"373","author":"D'Cruz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2024.03.001_bib0025","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1186\/s12885-021-09053-3","article-title":"Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database","volume":"21","author":"Wuhsou","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.brachy.2024.03.001_bib0026","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2009.01.005","article-title":"GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas","volume":"91","author":"Mazeron","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0027","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ijrobp.2019.08.058","article-title":"Precision adjuvant therapy based on detailed pathologic risk factors for resected oral cavity squamous cell carcinoma: long- term outcome comparison of CGMH and NCCN guidelines","volume":"106","author":"Lin","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.001_bib0028","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hed.24555","article-title":"Radiotherapy in early-stage tongue squamous cell carcinoma with minor adverse features: RT in early-stage tongue SCC with minor adverse features","volume":"39","author":"Katz","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.brachy.2024.03.001_bib0029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1748-717X-5-43","article-title":"Clinical outcomes for T1-2N0-1oral tongue patients underwent surgery with and without postoperative radiotherapy","volume":"5","author":"Shim","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.joms.2018.01.014","article-title":"Postoperative radiotherapy for oral squamous cell carcinoma with histologic risk factors: are we over-treating?","volume":"76","author":"Liu","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.brachy.2024.03.001_bib0031","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2022.10.035","article-title":"AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC)","volume":"177","author":"Merlotti","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0032","first-page":"38","article-title":"Improving the rate of negative margins on local recurrence in T1\/2 oral squamous cell carcinoma: a prospective randomized controlled study","author":"Amit","year":"2020","journal-title":"Head and Neck"},{"key":"10.1016\/j.brachy.2024.03.001_bib0033","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamaoto.2016.4238","article-title":"A proposal to redefine close surgical margins in squamous cell carcinoma of the oral tongue","volume":"143","author":"Zanoni","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.brachy.2024.03.001_bib0034","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00428-021-03063-z","article-title":"The prognostic role of histologic grade, worst pattern of invasion., and tumor budding in early oral tongue squamous cell carcinoma: a comparative study","volume":"479","author":"Xu","year":"2021","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.brachy.2024.03.001_bib0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.pas.0000149687.90710.21","article-title":"Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival","volume":"29","author":"Brandwein \u2013 Gensler","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.brachy.2024.03.001_bib0036","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1200\/JCO.20.03637","article-title":"Nack dissections based on sentinel lymph node navigation versus elective neck dissections in early oral cancers: A randomized, multicenter, and noninferiority trial","volume":"39","author":"Hasegawa","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.brachy.2024.03.001_bib0037","doi-asserted-by":"crossref","first-page":"297","DOI":"10.21053\/ceo.2022.01445","article-title":"Prediction of occult lymph node metastasis in early tongue cancer","volume":"15","author":"Kwon","year":"2022","journal-title":"Clin. Exp. Otorhinolaryngol."}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:37:56Z","timestamp":1740746276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1538472124000436"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.03.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative high-dose-rate brachytherapy alone in stage T1-3N0M0 oral cancer with negative prognostic factors: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}